Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

[mRNA expression of telomere protection protein TIN2 and POT1 in bone marrow of patients with myelodysplastic syndrome].

Ye F, He YM, Li GX, Wang LN, Jia N, Ma RX, Ma YP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):110-5. doi: 10.7534/j.issn.1009-2137.2013.01.023. Chinese.

PMID:
23484702
2.

Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.

Butler KS, Hines WC, Heaphy CM, Griffith JK.

Cancer Med. 2012 Oct;1(2):165-75. doi: 10.1002/cam4.14. Epub 2012 Jul 24.

3.

Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study.

Liu B, Yan R, Zhang J, Wang B, Sun H, Cui X.

Turk J Haematol. 2017 Aug 2;34(3):200-206. doi: 10.4274/tjh.2016.0364. Epub 2017 Apr 13.

4.

[Change of cytokine expressions on bone marrow mesenchymal stem cells in patients with bone marrow failure syndromes and its significance].

Yang SM, Lu SF, Fei XM, Zhang JF, Shen WY, Li JY, Lu H.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1560-3. Chinese.

PMID:
21176370
5.

[mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients].

Fei CM, Gu SC, Zhao YS, Guo J, Li X, Chang CK.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec;22(6):1656-60. doi: 10.7534/j.issn.1009-2137.2014.06.029. Chinese.

PMID:
25543492
6.

Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.

Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.

Leukemia. 1996 Jan;10(1):20-6.

PMID:
8558932
7.

CXXC4 mRNA levels are associated with clinicopathological parameters and survival of myelodysplastic syndrome patients.

Li S, Fan R, Zhao XL, Wang XQ.

Leuk Res. 2014 Sep;38(9):1072-8. doi: 10.1016/j.leukres.2014.07.002. Epub 2014 Jul 14.

PMID:
25085016
8.

[Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].

Lu D, Qin YZ, Li LD, Shi HX, Lai YY, Liu YR.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):370-6. doi: 10.7534/j.issn.1009-2137.2014.02.019. Chinese.

PMID:
24763007
9.

Changes in the expression of telomere maintenance genes might play a role in the pathogenesis of systemic lupus erythematosus.

Zhou JG, Qing YF, Yang QB, Xie WG, Zhao MC.

Lupus. 2011 Jul;20(8):820-8. doi: 10.1177/0961203310397964.

PMID:
21693493
10.

[Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].

Feng XM, Xu HZ, Zhang JY, Yin DM, Liu MM, Sui XH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):1038-42. doi: 10.7534/j.issn.1009-2137.2014.04.028. Chinese.

PMID:
25130824
11.

[Expression of cyclin A1 mRNA in patients with myelodysplastic syndrome and its clinical significance].

Jia JS, Xu SR.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):377-81. Chinese.

PMID:
19379570
12.

Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.

Gianelli U, Fracchiolla NS, Cortelezzi A, Pellegrini C, Savi F, Moro A, Grimoldi MG, Deliliers GL, Coggi G, Bosari S.

Ann Hematol. 2007 Mar;86(3):185-9. Epub 2006 Nov 24.

PMID:
17124585
13.

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.

Wimazal F, Krauth MT, Vales A, Böhm A, Agis H, Sonneck K, Aichberger KJ, Mayerhofer M, Simonitsch-Klupp I, Müllauer L, Sperr WR, Valent P.

Leuk Lymphoma. 2006 Mar;47(3):451-60.

PMID:
16396768
14.

TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.

Frescas D, de Lange T.

Mol Cell Biol. 2014 Apr;34(7):1349-62. doi: 10.1128/MCB.01052-13. Epub 2014 Jan 27.

15.

[Gene expression in patients with myelodysplastic syndrome].

Chen BA, Zhang B, Gao C, Gao F, Xia GH, Shao ZY, Ding JH, Zhao G, Chen J, Wang J, Song HH, Bao W, Zhong YJ, Pei XP, Wang F, Gu ZZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):666-70. Chinese.

PMID:
20561424
16.

[Telomere length and gene expression of shelterin in CD3(+) T cell of severe aplastic anemia patients].

Wang T, Fu R, Wang HQ, Qu W, Ruan EB, Wang GJ, Liu H, Wu YH, Wang XM, Song J, Xing LM, Guan J, Li LJ, Liu H, Liu CY, Wang YH, Jiang HJ, Ding K, Dong XF, Wang HL, Zhang T, Shao ZH.

Zhonghua Yi Xue Za Zhi. 2013 May 28;93(20):1533-6. Chinese.

PMID:
24028717
17.

[Expression of tumor suppressor gene pten in patients with myelodysplastic syndrome and acute myeloid leukemia].

Zou XL, Liu T, Meng WT, Huang XO.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Oct;16(5):1086-90. Chinese.

PMID:
18928601
18.

[Detection of methylation levels of multi-genes by real-time PCR in patients with myelodysplastic syndrome].

Wang YC, DU X, Geng SX, Li YY, Weng JY, Lu ZS, Zhong LY, Deng CX, Lai PL, Huang X.

Zhonghua Xue Ye Xue Za Zhi. 2011 Apr;32(4):254-8. Chinese.

PMID:
21569709
19.

[IL-32 mRNA Expression of Bone Marrow Stromal Cells and Its Correlation with Cell Apoptosis in Patients with Myelodysplastic Syndrome].

Zhang YY, Xu L, Li DQ, Shao JH, Chen P, Zhao HY, Dong XB, Gu LP, Wu W.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Jun;24(3):773-8. doi: 10.7534/j.issn.1009-2137.2016.03.026. Chinese.

PMID:
27342508
20.

[Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].

Wu LY, Li X, Chang CK, Ying SX, Pu Q.

Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):549-54. Chinese.

PMID:
18078133

Supplemental Content

Support Center